CVS Health logged a -2.4% change during today's afternoon session, and is now trading at a price of $67.38 per share. The S&P 500 index moved 1.0%. CVS's trading volume is 9,528,226 compared to the stock's average volume of 8,262,446.
CVS Health trades -25.27% away from its average analyst target price of $90.16 per share. The 22 analysts following the stock have set target prices ranging from $76.0 to $110.0, and on average have given CVS Health a rating of buy.
If you are considering an investment in CVS, you'll want to know the following:
-
CVS Health's current price is 22.1% above its Graham number of $55.18, which implies that at its current valuation it does not offer a margin of safety
-
CVS Health has moved -30.0% over the last year, and the S&P 500 logged a change of 13.0%
-
Based on its trailing earnings per share of 2.19, CVS Health has a trailing 12 month Price to Earnings (P/E) ratio of 30.8 while the S&P 500 average is 15.97
-
CVS has a forward P/E ratio of 7.8 based on its forward 12 month price to earnings (EPS) of $8.6 per share
-
The company has a price to earnings growth (PEG) ratio of 1.97 — a number near or below 1 signifying that CVS Health is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 1.19 compared to its sector average of 4.29
-
CVS Health Corporation provides health services in the United States.
-
Based in Woonsocket, the company has 219,000 full time employees and a market cap of $86.54 Billion. CVS Health currently returns an annual dividend yield of 3.3%.
